ReGARDD - Regulatory Guidance for Academic Research of Drugs and Devices
ReGARDD provides academic researchers with the regulatory tools and resources necessary to successfully navigate the pathway from discovery to clinical implementation of new drugs, biologics and medical devices.
The CTSA program aims to strengthen and support the spectrum of translational research by accelerating the process of translating laboratory discoveries into treatments for patients, training a new generation of clinical and translational researchers, and engaging communities in clinical research efforts.
To learn about upcoming educational events or updates from ReGARDD, please provide your contact information: